HTLV-1 infection poses a risk for leukemia and other ailments. Now the elusive cellular receptor for this pathogen has finally been identified, and it is the same receptor that allows glucose to enter cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Poiesz, B.J. et al. Proc. Natl. Acad. Sci. USA 77, 7415–7419 (1980).
Manel, N. et al. Cell 115, 449–459 (2003).
Overbaugh, J., Miller, A.D. & Eiden, M.V. Microbiol. Mol. Biol. Rev. 65, 371–389 (2001).
Manel, N. et al. Blood 101, 1913–1918 (2003).
Nath, M.D. et al. Blood 101, 3085–3092 (2003).
Sommerfelt, M.A. & Weiss, R.A. Virology 176, 58–69 (1990).
Stoye, J.P. Proc. Natl. Acad. Sci. USA 99, 11549–11551 (2002).
Igakura, T. et al. Science 299, 1713–1715 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Overbaugh, J. HTLV-1 sweet-talks its way into cells. Nat Med 10, 20–21 (2004). https://doi.org/10.1038/nm0104-20
Issue Date:
DOI: https://doi.org/10.1038/nm0104-20
This article is cited by
-
Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4+ T cells
Nature Medicine (2008)
-
A case of human T lymphotropic virus type I-associated synovial swelling
Nature Clinical Practice Rheumatology (2007)
